RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lang Wu to Antineoplastic Agents

This is a "connection" page, showing publications Lang Wu has written about Antineoplastic Agents.
Connection Strength

0.267
  1. Wang S, Wang J, Lu X, Liu M, Liu Y, Li M, Kong X, Wu L, Guan Q, Zhang W. Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation. Eur J Med Chem. 2024 Jun 05; 272:116458.
    View in: PubMed
    Score: 0.140
  2. Li H, Shi L, Wei J, Zhang C, Zhou Z, Wu L, Liu W. Cellular uptake and anticancer activity of salvianolic acid B phospholipid complex loaded nanoparticles in head and neck cancer and precancer cells. Colloids Surf B Biointerfaces. 2016 Nov 01; 147:65-72.
    View in: PubMed
    Score: 0.082
  3. Zhang L, Zhang WG, Ma EL, Wu L, Bao K, Wang XL, Wang YL, Song HR. Synthesis and antiproliferative in-vitro activity of natural flavans and related compounds. Arch Pharm (Weinheim). 2007 Dec; 340(12):650-5.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support